364 related articles for article (PubMed ID: 27104502)
1. Properties of the Sodium Naproxen-Lactose-Tetrahydrate Co-Crystal upon Processing and Storage.
Sovago I; Wang W; Qiu D; Raijada D; Rantanen J; Grohganz H; Rades T; Bond AD; Löbmann K
Molecules; 2016 Apr; 21(4):509. PubMed ID: 27104502
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
[TBL] [Abstract][Full Text] [Related]
3. Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen/indomethacin.
Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS
Eur J Pharm Biopharm; 2016 Dec; 109():140-148. PubMed ID: 27746228
[TBL] [Abstract][Full Text] [Related]
4. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
Lim AW; Löbmann K; Grohganz H; Rades T; Chieng N
J Pharm Pharmacol; 2016 Jan; 68(1):36-45. PubMed ID: 26663364
[TBL] [Abstract][Full Text] [Related]
5. Improvement of the physicochemical properties of Co-amorphous naproxen-indomethacin by naproxen-sodium.
Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS
Int J Pharm; 2017 Jun; 526(1-2):88-94. PubMed ID: 28392278
[TBL] [Abstract][Full Text] [Related]
6. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
Chieng N; Aaltonen J; Saville D; Rades T
Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
[TBL] [Abstract][Full Text] [Related]
7. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
8. Preparation and recrystallization behavior of spray-dried co-amorphous naproxen-indomethacin.
Beyer A; Radi L; Grohganz H; Löbmann K; Rades T; Leopold CS
Eur J Pharm Biopharm; 2016 Jul; 104():72-81. PubMed ID: 27130786
[TBL] [Abstract][Full Text] [Related]
9. Melt extrusion vs. spray drying: The effect of processing methods on crystalline content of naproxen-povidone formulations.
Haser A; Cao T; Lubach J; Listro T; Acquarulo L; Zhang F
Eur J Pharm Sci; 2017 May; 102():115-125. PubMed ID: 28259831
[TBL] [Abstract][Full Text] [Related]
10. [The development of co-amorphous drug systems].
Yao J; Shi NQ; Wang XL
Yao Xue Xue Bao; 2013 May; 48(5):648-54. PubMed ID: 23888685
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo comparison between crystalline and co-amorphous salts of naproxen-arginine.
Kasten G; Lobo L; Dengale S; Grohganz H; Rades T; Löbmann K
Eur J Pharm Biopharm; 2018 Nov; 132():192-199. PubMed ID: 30266670
[TBL] [Abstract][Full Text] [Related]
12. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
13. Formation of physically stable amorphous drugs by milling with Neusilin.
Gupta MK; Vanwert A; Bogner RH
J Pharm Sci; 2003 Mar; 92(3):536-51. PubMed ID: 12587115
[TBL] [Abstract][Full Text] [Related]
14. Co-milled API-lactose systems for inhalation therapy: impact of magnesium stearate on physico-chemical stability and aerosolization performance.
Lau M; Young PM; Traini D
Drug Dev Ind Pharm; 2017 Jun; 43(6):980-988. PubMed ID: 28122460
[TBL] [Abstract][Full Text] [Related]
15. Milling induced amorphisation and recrystallization of α-lactose monohydrate.
Badal Tejedor M; Pazesh S; Nordgren N; Schuleit M; Rutland MW; Alderborn G; Millqvist-Fureby A
Int J Pharm; 2018 Feb; 537(1-2):140-147. PubMed ID: 29262302
[TBL] [Abstract][Full Text] [Related]
16. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
[TBL] [Abstract][Full Text] [Related]
17. Solid-state amorphization of rebamipide and investigation on solubility and stability of the amorphous form.
Xiong X; Xu K; Li S; Tang P; Xiao Y; Li H
Drug Dev Ind Pharm; 2017 Feb; 43(2):283-292. PubMed ID: 27648489
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Amorphous and Co-Amorphous Simvastatin Formulations Prepared by Spray Drying.
Craye G; Löbmann K; Grohganz H; Rades T; Laitinen R
Molecules; 2015 Dec; 20(12):21532-48. PubMed ID: 26633346
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical stability of crystalline sugars and their spray-dried forms: dependence upon relative humidity and suitability for use in powder inhalers.
Naini V; Byron PR; Phillips EM
Drug Dev Ind Pharm; 1998 Oct; 24(10):895-909. PubMed ID: 9876544
[TBL] [Abstract][Full Text] [Related]
20. Multivariate Quantification of the Solid State Phase Composition of Co-Amorphous Naproxen-Indomethacin.
Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS
Molecules; 2015 Oct; 20(10):19571-87. PubMed ID: 26516832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
